Navigation Links
NHGRI aims to make DNA sequencing faster, more cost effective

s phased award will increase if specific milestones are met in the initial experiments.
  • J. Michael Ramsey, Ph.D., University of North Carolina, Chapel Hill,$3.8 million (4 years),"Nanoscale Fluidic Technologies for Rapidly Sequencing Single DNA Molecules"

A nanometer is one-billionth of a meter, much too small to be seen with a conventional lab microscope. Several groups are developing nanopores (holes about 2 nanometers in diameter) for use as DNA sequence transducers and propose to detect an electrical, or ionic, signal from individual DNA molecules. The goal of this group is to fabricate nanoscale channels in which single molecules of DNA will pass between nano-electrodes that are less than 2 nanometers apart, to measure an electric current that will identify individual bases.

  • Xiaohua Huang, Ph.D., University of California, San Diego, La Jolla,$275,000 (1 year),"Genome Sequencing by Ligation Using Nano-Arrays of Single DNA Molecules"

Using an experimental method for DNA sequencing called "single molecule sequencing by ligation," this project aims to develop a method for fabricating high-density arrays of wells with sub-micrometer dimensions for ordering single nanoparticles and DNA molecules. The investigator will attempt to demonstrate that more than 1 billion individual DNA molecules can be sequenced in massive parallel though a process involving cyclic sequencing by ligation, a process where an enzyme is used to join pieces of DNA together. This phased award will increase if specific milestones are met in the initial experiments.

  • Amit Meller, Ph.D., Boston University, Boston,$2.2 million (3 years),"High-Throughput DNA Sequencing Using Design Polymers and Nanopore Arrays"

This group along with their industrial partner LingVitae AS, will continue to implement a novel approach previously funded through this program in which a nanopore is used to simultaneously detect electrical
'"/>

Source:NIH/National Human Genome Research Institute


Page: 1 2 3 4 5 6

Related biology news :

1. NHGRI targets 12 more organisms for genome sequencing
2. NHGRI Selects 13 More Organisms for Genome Sequencing
3. NHGRI expands effort to revolutionize sequencing technologies
4. NHGRI announces new sequencing targets
5. NHGRI announces latest sequencing targets
6. Color-blind method opens new doors in DNA sequencing
7. Gene sequencing explains bioremediation bug
8. Detection of DNA on nanotubes offers new sensing, sequencing technologies
9. Genome sequencing is for ecologists, too
10. Nanopore method could revolutionize genome sequencing
11. Mitochondrial DNA sequencing tool updated
Post Your Comments:
(Date:12/4/2009)...am (EEG) is widely used by physicians and scientis...gical disorders. However, it has remained largely ... exact view of what is happening inside the brain....ical Cybernetics in Tbingen, Germany, have now fou...ithin the brain to that measured with EEG. These f...
(Date:12/4/2009)...al model of heart cells, University of Iowa invest...zyme, calmodulin kinase II (CaM kinase), disrupts ...study, which also involved Columbia University, wa...putational Biology . , "Recently, researchers h...II as a critical regulator of the heart,s response...
(Date:12/3/2009)..., Dec. 3 BIO-key Interna...in wireless public safety and finger-based biometr...rity of its shareholders at a Special Shareholder ...y,s Law Enforcement Division to Interact911 Mobile... in favor and 1.2% were opposed. ,, (Logo: htt...
Breaking Biology News(10 mins):How to read brain activity? 2U-Iowa study helps advance heart-related research 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Union of American Physicians and Dentists 3A Court Appointee El Sabaawi Practicing Medicine Without a License 3F 52846 1Union of American Physicians and Dentists 3A Court Appointee El Sabaawi Practicing Medicine Without a License 3F 52846 2SEQUENOM Announces Launch of MassARRAY Compact 96 System 13217 1SEQUENOM Announces Launch of MassARRAY Compact 96 System 13217 2SEQUENOM Announces Launch of MassARRAY Compact 96 System 13217 3SEQUENOM Announces Launch of MassARRAY Compact 96 System 13217 4Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 1Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 2Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 3Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 4Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 5Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 6
... WHITE PLAINS, NY Babies born preterm were more t... full-term infants, according to a new analysis of...e this week in the Springer journal Maternal and C... before 37 completed weeks gestation, is a growing... Dimes. More than a half million babies are born t...
...own as neurons process information by joining into...her across junctions called synapses. But neurons ...Josh Huang, Ph.D., in a lot of cases, they connect... Dr. Huang, a professor at Cold Spring Harbor Lab...olecules guiding this highly specific neuronal tar...
...iologists from Austria and Singapore developed a t... between biology and art. In an article recently p...fasebj.org ) and scheduled for the August 2008 pri... able to coator paintviruses with proteins. This b... efficiency of some forms of gene therapy, help tr...
Other Biology News:Analysis of millions of US births shows association between birth defects and preterm birth 2Scientists discover a molecular scaffold that guides connections between brain cells 2Scientists discover a molecular scaffold that guides connections between brain cells 3Scientists 'paint' viruses to track their fate in the body 2
(Date:12/2/2009)..., Dec. 2 Peregrine Pharm...ompletion of patient enrollment in a dose confirma...ts with relapsed glioblastoma multiforme (GBM), th...geted monoclonal antibody linked to a radioisotope...GBM. Cotara specifically targets cells at the cen...
(Date:12/2/2009)...e Netherlands, December 2 Pepscan ...mpany focusing on protein mimicking,technology for...nced that it,has appointed Wim E.M. Mol, Ph.D. as ...ll be responsible for all of Pepscans corporate fu...irection of the company. He brings to,Pepscan more...
(Date:12/2/2009)...Dec. 2 S*BIO Pte Ltd today announc...itor, SB1518, at The American Society of Hematolog...s. ,, Data will be presented on the clinical re...1518 detailing its safety, tolerability and pharma...levels ranging from 100 to 600 mg. These doses wer...
(Date:12/2/2009)... 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. ...al biopharmaceutical company focused on endocrine .... Food and Drug Administration (FDA) has granted F...athway inhibitor compound, perifosine (KRX-0401), ...myeloma. Keryx Biopharmaceuticals, Inc. ("Keryx") ...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
...,Bulletin Board: AIMM) today reported a net loss o...ed, for the three months ended September 30, 2008,...per share basic and,diluted, for the three months ...d September 30, 2008, the net loss was $216,000, o... net loss of $62,000, or break even per,share basi...
...aq: OSTE ), a leader in the emerging field of bio... today that its next generation grafting,material ...M) Bone Graft., Robert M. Wynalek, Osteotech,s Pr...line of next generation bone regeneration products...a high performing, cost,effective bone graft mater...
...HD) today announced that its executives will be sp...invited investors to participate via webcast., ...oenix, AZ Friday, November 14, 2008 at 8.00 a...Conference, New York, NY Tuesday, December 2,...s, To access the live webcasts for these events, ...
Other Biology Technology:AutoImmune Inc. Reports 2008 Third Quarter Financial Results 2AutoImmune Inc. Reports 2008 Third Quarter Financial Results 3Osteotech's Next Generation Grafting Material, MagniFuse(TM) Bone Graft, a Breakthrough in Bone Regeneration; MagniFuse(TM) Bone Graft seeks to redefine the standard of care in the U.S. bone graft substitute market estimated to be in excess of $1.2 billio 2Osteotech's Next Generation Grafting Material, MagniFuse(TM) Bone Graft, a Breakthrough in Bone Regeneration; MagniFuse(TM) Bone Graft seeks to redefine the standard of care in the U.S. bone graft substitute market estimated to be in excess of $1.2 billio 3Cepheid to Webcast Upcoming Financial Presentations 2
Rabbit Anti-Orexin Prepro Polyclonal Antibody, Unconjugated from Abcam
Anti-Human C5a / C5a des-Arg (neo-epitode) Monoclonal Antibody, Unconjugated, Clone 2952 from Cell Sciences
Rabbit Anti-Human Ubiquitin-conjugating enzyme E2N Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Anti-Acetyl CoA Carboxylase Antibody, Unconjugated from Cell Signaling Technology
Biology Products: